Literature DB >> 16010421

Bone morphogenetic protein 2 (BMP-2) induces in vitro invasion and in vivo hormone independent growth of breast carcinoma cells.

Joachim H Clement1, Martin Raida, Jörg Sänger, Roy Bicknell, Jingwen Liu, Anke Naumann, Annette Geyer, Anja Waldau, Peter Hortschansky, Andreas Schmidt, Klaus Höffken, Stefan Wölft, Adrian L Harris.   

Abstract

Breast cancer cell lines migrated towards a BMP-2 source depending on BMP-2 concentration. After a short exposure to BMP-2, the cells were able to migrate through matrigel. MCF-7 cells transfected with the BMP-2 gene also showed enhanced migratory properties and high expression of the metastasis-related gene BCSG1. In a xenograft model without estrogen supplementation MCF-7/BMP-2 cells formed tumors. These tumors were characterised by an enhanced vasculature and the formation of chondroid and osseous structures. In conclusion elevated levels of BMP-2 enhance the tumorigenic properties of breast carcinoma cells and drive the cells towards a more aggressive phenotype with estrogen independent growth.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16010421

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  41 in total

1.  Bone morphogenetic protein 4 (BMP4) is required for migration and invasion of breast cancer.

Authors:  Dan Guo; Jiayi Huang; Jianping Gong
Journal:  Mol Cell Biochem       Date:  2011-12-14       Impact factor: 3.396

2.  Novel bone morphogenetic protein receptor inhibitor JL5 suppresses tumor cell survival signaling and induces regression of human lung cancer.

Authors:  Jenna H Newman; David J Augeri; Rachel NeMoyer; Jyoti Malhotra; Elaine Langenfeld; Charles B Chesson; Natalie S Dobias; Michael J Lee; Saeed Tarabichi; Sachin R Jhawar; Praveen K Bommareddy; Sh'Rae Marshall; Evita T Sadimin; John E Kerrigan; Michael Goedken; Christine Minerowicz; Salma K Jabbour; Shengguo Li; Mary O Carayannopolous; Andrew Zloza; John Langenfeld
Journal:  Oncogene       Date:  2018-04-06       Impact factor: 9.867

3.  Disruption of bone morphogenetic protein receptor 2 (BMPR2) in mammary tumors promotes metastases through cell autonomous and paracrine mediators.

Authors:  Philip Owens; Michael W Pickup; Sergey V Novitskiy; Anna Chytil; Agnieszka E Gorska; Mary E Aakre; James West; Harold L Moses
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-16       Impact factor: 11.205

Review 4.  Emerging roles of the bone morphogenetic protein pathway in cancer: potential therapeutic target for kinase inhibition.

Authors:  Pawina Jiramongkolchai; Philip Owens; Charles C Hong
Journal:  Biochem Soc Trans       Date:  2016-08-15       Impact factor: 5.407

5.  Co-evolution of breast-to-brain metastasis and neural progenitor cells.

Authors:  Josh Neman; Cecilia Choy; Claudia M Kowolik; Athena Anderson; Vincent J Duenas; Sarah Waliany; Bihong T Chen; Mike Y Chen; Rahul Jandial
Journal:  Clin Exp Metastasis       Date:  2013-02-28       Impact factor: 5.150

6.  ΔNp63α-mediated activation of bone morphogenetic protein signaling governs stem cell activity and plasticity in normal and malignant mammary epithelial cells.

Authors:  Amanda L Balboni; Justine A Hutchinson; Andrew J DeCastro; Pratima Cherukuri; Karen Liby; Michael B Sporn; Gary N Schwartz; Wendy A Wells; Lorenzo F Sempere; Paul B Yu; James DiRenzo
Journal:  Cancer Res       Date:  2012-12-14       Impact factor: 12.701

7.  The correlation of bone morphogenetic protein 2 with poor prognosis in glioma patients.

Authors:  Xiangshan Yang; Daotang Li; Shaomei Cheng; Kaixi Fan; Lijun Sheng; Jing Zhang; Bin Feng; Zhongfa Xu
Journal:  Tumour Biol       Date:  2014-08-07

8.  Chordin-Like 1 Suppresses Bone Morphogenetic Protein 4-Induced Breast Cancer Cell Migration and Invasion.

Authors:  Chanèle Cyr-Depauw; Jason J Northey; Sébastien Tabariès; Matthew G Annis; Zhifeng Dong; Sean Cory; Michael Hallett; Jonathan P Rennhack; Eran R Andrechek; Peter M Siegel
Journal:  Mol Cell Biol       Date:  2016-05-02       Impact factor: 4.272

9.  A dose- and time-controllable syngeneic animal model of breast cancer microcalcification.

Authors:  Fangbing Liu; Preeti Misra; Elaine P Lunsford; Joanne T Vannah; Yuxia Liu; Robert E Lenkinski; John V Frangioni
Journal:  Breast Cancer Res Treat       Date:  2009-09-17       Impact factor: 4.872

10.  Bone morphogenetic protein-2 levels are elevated in the patients with gastric cancer and correlate with disease progression.

Authors:  Yong Park; Myoung Hee Kang; Hee Yeon Seo; Joong Min Park; Chul Won Choi; Yeul Hong Kim; In Sun Kim; Jun Suk Kim; Sang Cheul Oh
Journal:  Med Oncol       Date:  2009-11-19       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.